Ingo Ott

13.7k total citations · 4 hit papers
205 papers, 11.8k citations indexed

About

Ingo Ott is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Ingo Ott has authored 205 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Organic Chemistry, 128 papers in Oncology and 45 papers in Molecular Biology. Recurrent topics in Ingo Ott's work include Metal complexes synthesis and properties (117 papers), Ferrocene Chemistry and Applications (67 papers) and N-Heterocyclic Carbenes in Organic and Inorganic Chemistry (44 papers). Ingo Ott is often cited by papers focused on Metal complexes synthesis and properties (117 papers), Ferrocene Chemistry and Applications (67 papers) and N-Heterocyclic Carbenes in Organic and Inorganic Chemistry (44 papers). Ingo Ott collaborates with scholars based in Germany, Austria and United States. Ingo Ott's co-authors include Ronald Gust, Nils Metzler‐Nolte, Gilles Gasser, Riccardo Rubbiani, William S. Sheldrick, Luciano Oehninger, Stefan Wölfl, Hamed Alborzinia, Claudia Schmidt and Suzan Can and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Circulation.

In The Last Decade

Ingo Ott

200 papers receiving 11.7k citations

Hit Papers

Organometallic Anticancer... 2007 2026 2013 2019 2010 2009 2007 2012 400 800 1.2k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ingo Ott 8.1k 6.5k 2.6k 1.7k 1.4k 205 11.8k
Abraha Habtemariam 6.1k 0.8× 6.0k 0.9× 1.9k 0.8× 1.8k 1.1× 2.0k 1.4× 127 9.2k
Michael A. Jakupec 8.7k 1.1× 10.5k 1.6× 3.4k 1.3× 2.2k 1.3× 2.0k 1.4× 228 14.1k
M. Galanski 4.3k 0.5× 5.3k 0.8× 1.9k 0.7× 1.4k 0.9× 947 0.7× 193 8.0k
Vladimir B. Arion 5.7k 0.7× 5.9k 0.9× 1.6k 0.6× 1.7k 1.0× 2.2k 1.6× 248 9.0k
Luigi Messori 6.7k 0.8× 8.9k 1.4× 4.9k 1.9× 2.6k 1.5× 1.9k 1.4× 388 15.9k
Ronald Gust 5.3k 0.7× 4.1k 0.6× 2.6k 1.0× 896 0.5× 932 0.7× 271 9.4k
Nicholas P. Farrell 5.8k 0.7× 7.9k 1.2× 4.8k 1.8× 1.5k 0.9× 1.0k 0.7× 294 10.9k
Gianni Sava 7.1k 0.9× 8.8k 1.4× 3.2k 1.2× 1.8k 1.0× 1.5k 1.1× 230 12.2k
Wee Han Ang 3.8k 0.5× 3.9k 0.6× 2.0k 0.8× 1.8k 1.1× 880 0.6× 135 7.7k
Christian G. Hartinger 11.1k 1.4× 12.2k 1.9× 4.2k 1.6× 2.5k 1.5× 2.5k 1.8× 275 17.6k

Countries citing papers authored by Ingo Ott

Since Specialization
Citations

This map shows the geographic impact of Ingo Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Ott more than expected).

Fields of papers citing papers by Ingo Ott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Ott. The network helps show where Ingo Ott may publish in the future.

Co-authorship network of co-authors of Ingo Ott

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo Ott. A scholar is included among the top collaborators of Ingo Ott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo Ott. Ingo Ott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marchiò, Luciano, et al.. (2025). Gold‐Dithiocarbamato Glycoconjugates as Potential Anticancer Agents: Design, Physico‐Chemical Characterization, and In Vitro Biological Activity. ChemBioChem. 26(22). e202500447–e202500447. 1 indexed citations
4.
Gil‐Moles, María, M. Elena Olmos, José M. López‐de‐Luzuriaga, Ingo Ott, & M. Concepción Gimeno. (2024). A dual approach to cancer treatment: gold(i) terpyridine derivatives as DNA binders and inhibitors of mammalian thioredoxin reductase. Inorganic Chemistry Frontiers. 11(15). 4802–4814. 3 indexed citations
5.
Fontrodona, Xavier, Isabel Romero, Paulo J. Costa, et al.. (2024). Paraptotic Cell Death as an Unprecedented Mode of Action Observed for New Bipyridine-Silver(I) Compounds Bearing Phosphane Coligands. Journal of Medicinal Chemistry. 67(8). 6081–6098. 6 indexed citations
6.
Bockfeld, Dirk, Bianka Karge, Thomas Bannenberg, et al.. (2024). Synthesis of N-heterocyclic carbene gold(i) complexes from the marine betaine 1,3-dimethylimidazolium-4-carboxylate. Dalton Transactions. 53(5). 1942–1946. 6 indexed citations
8.
Karge, Bianka, Petra Lippmann, Peter G. Jones, et al.. (2024). Silver Organometallics that are Highly Potent Thioredoxin and Glutathione Reductase Inhibitors: Exploring the Correlations of Solution Chemistry with the Strong Antibacterial Effects. ACS Infectious Diseases. 10(5). 1753–1766. 12 indexed citations
9.
Schmidt, Claudia, et al.. (2023). Potent Anticancer Activity of a Dinuclear Gold(I) bis‐N‐Heterocyclic Imine Complex Related to Thioredoxin Reductase Inhibition in Vitro. ChemPlusChem. 89(4). e202300557–e202300557. 6 indexed citations
10.
Kopacka, Holger, Klaus Wurst, Thomas Müller, et al.. (2023). Clathrochelate Complexes Containing Axial Cymantrene and Tromancenium Moieties. European Journal of Inorganic Chemistry. 26(26). e202300368–e202300368. 6 indexed citations
11.
Serebryanskaya, Tatiyana V., Mikhail A. Kinzhalov, Pavel V. Gushchin, et al.. (2020). Water soluble palladium(ii) and platinum(ii) acyclic diaminocarbene complexes: solution behavior, DNA binding, and antiproliferative activity. New Journal of Chemistry. 44(15). 5762–5773. 18 indexed citations
12.
Zhang, Jing‐Jing, Mohamed A. Abu el Maaty, Claudia Schmidt, et al.. (2020). Ein Multitarget‐Gold(I)‐Komplex induziert Zytotoxizität im Zusammenhang mit Aneuploidie in HCT‐116‐Kolorektalkarzinomzellen. Angewandte Chemie. 132(38). 16940–16945. 10 indexed citations
13.
Zhang, Jing‐Jing, Mohamed A. Abu el Maaty, Claudia Schmidt, et al.. (2020). A Multitarget Gold(I) Complex Induces Cytotoxicity Related to Aneuploidy in HCT‐116 Colorectal Carcinoma Cells. Angewandte Chemie International Edition. 59(38). 16795–16800. 59 indexed citations
14.
Neundorf, Ines, Petra Lippmann, Ingo Ott, et al.. (2020). Cyclometalated Pt Complexes of CNC Pincer Ligands: Luminescence and Cytotoxic Evaluation. Organometallics. 39(5). 746–756. 41 indexed citations
15.
Gil‐Moles, María, et al.. (2020). Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike‐ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics**. Chemistry - A European Journal. 26(66). 15140–15144. 73 indexed citations
16.
Theobald, Jannick, et al.. (2018). A Ruthenium(II) N-Heterocyclic Carbene (NHC) Complex with Naphthalimide Ligand Triggers Apoptosis in Colorectal Cancer Cells via Activating the ROS-p38 MAPK Pathway. International Journal of Molecular Sciences. 19(12). 3964–3964. 29 indexed citations
18.
Kunick, Conrad & Ingo Ott. (2010). Metallkomplexe als Proteinkinase‐Hemmstoffe. Angewandte Chemie. 122(31). 5354–5356. 5 indexed citations
19.
Ott, Ingo & Ronald Gust. (2007). Non Platinum Metal Complexes as Anti‐cancer Drugs. Archiv der Pharmazie. 340(3). 117–126. 525 indexed citations breakdown →
20.
Ott, Ingo & Ronald Gust. (2007). Preclinical and Clinical Studies on the Use of Platinum Complexes for Breast Cancer Treatment. Anti-Cancer Agents in Medicinal Chemistry. 7(1). 95–110. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026